Risk of new-onset diabetes with statin use should not be overemphasised
This study examined diabetes outcomes among Tricare beneficiaries who were evaluated between 1 October 2003 and 1 March 2012. Participants were divided into statin users and non-users. Patients who, at baseline, had a pre-existing disease indicative of cardiovascular diseases, or any positive element of the Charlson comorbidity index, were excluded. A propensity score, using 42 baseline characteristics, was generated to match statin users and non-users. The main measurements included new-onset diabetes, diabetic complications and overweight/obesity. Findings...
Source: Evidence-Based Medicine - Category: Internal Medicine Authors: Chiang, C.-E., Wang, K.-L. Tags: Health policy, Clinical trials (epidemiology), Epidemiologic studies, Drugs: cardiovascular system, Stroke, Ischaemic heart disease, Diabetes Aetiology/Harm Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Epidemiology | Health | Heart | Heart Disease | Internal Medicine | Ischemic Stroke | Obesity | Sports Medicine | Statin Therapy | Stroke | Study